PU.1 controls fibroblast polarization and tissue fibrosis

Thomas Wohlfahrt, Simon Rauber, Steffen Uebe, Markus Luber, Alina Soare, Arif Ekici, Stefanie Weber, Alexandru Emil Matei, Chih Wei Chen, Christiane Maier, Emmanuel Karouzakis, Hans P. Kiener, Elena Pachera, Clara Dees, Christian Beyer, Christoph Daniel, Kolja Gelse, Andreas E. Kremer, Elisabeth Naschberger, Michael StürzlFalk Butter, Michael Sticherling, Susetta Finotto, Alexander Kreuter, Mark Kaplan, Astrid Jüngel, Steffen Gay, Stephen L. Nutt, David W. Boykin, Gregory M.K. Poon, Oliver Distler, Georg Schett, Jörg H.W. Distler, Andreas Ramming

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Fibroblasts are polymorphic cells with pleiotropic roles in organ morphogenesis, tissue homeostasis and immune responses. In fibrotic diseases, fibroblasts synthesize abundant amounts of extracellular matrix, which induces scarring and organ failure. By contrast, a hallmark feature of fibroblasts in arthritis is degradation of the extracellular matrix because of the release of metalloproteinases and degrading enzymes, and subsequent tissue destruction. The mechanisms that drive these functionally opposing pro-fibrotic and pro-inflammatory phenotypes of fibroblasts remain unknown. Here we identify the transcription factor PU.1 as an essential regulator of the pro-fibrotic gene expression program. The interplay between transcriptional and post-transcriptional mechanisms that normally control the expression of PU.1 expression is perturbed in various fibrotic diseases, resulting in the upregulation of PU.1, induction of fibrosis-associated gene sets and a phenotypic switch in extracellular matrix-producing pro-fibrotic fibroblasts. By contrast, pharmacological and genetic inactivation of PU.1 disrupts the fibrotic network and enables reprogramming of fibrotic fibroblasts into resting fibroblasts, leading to regression of fibrosis in several organs.

Original languageEnglish (US)
Pages (from-to)344-349
Number of pages6
JournalNature
Volume566
Issue number7744
DOIs
StatePublished - Feb 21 2019

Fingerprint

Fibrosis
Fibroblasts
Extracellular Matrix
Metalloproteases
Morphogenesis
Arthritis
Cicatrix
Homeostasis
Pharmacology
Phenotype
Gene Expression
Enzymes
Genes

ASJC Scopus subject areas

  • General

Cite this

Wohlfahrt, T., Rauber, S., Uebe, S., Luber, M., Soare, A., Ekici, A., ... Ramming, A. (2019). PU.1 controls fibroblast polarization and tissue fibrosis. Nature, 566(7744), 344-349. https://doi.org/10.1038/s41586-019-0896-x

PU.1 controls fibroblast polarization and tissue fibrosis. / Wohlfahrt, Thomas; Rauber, Simon; Uebe, Steffen; Luber, Markus; Soare, Alina; Ekici, Arif; Weber, Stefanie; Matei, Alexandru Emil; Chen, Chih Wei; Maier, Christiane; Karouzakis, Emmanuel; Kiener, Hans P.; Pachera, Elena; Dees, Clara; Beyer, Christian; Daniel, Christoph; Gelse, Kolja; Kremer, Andreas E.; Naschberger, Elisabeth; Stürzl, Michael; Butter, Falk; Sticherling, Michael; Finotto, Susetta; Kreuter, Alexander; Kaplan, Mark; Jüngel, Astrid; Gay, Steffen; Nutt, Stephen L.; Boykin, David W.; Poon, Gregory M.K.; Distler, Oliver; Schett, Georg; Distler, Jörg H.W.; Ramming, Andreas.

In: Nature, Vol. 566, No. 7744, 21.02.2019, p. 344-349.

Research output: Contribution to journalArticle

Wohlfahrt, T, Rauber, S, Uebe, S, Luber, M, Soare, A, Ekici, A, Weber, S, Matei, AE, Chen, CW, Maier, C, Karouzakis, E, Kiener, HP, Pachera, E, Dees, C, Beyer, C, Daniel, C, Gelse, K, Kremer, AE, Naschberger, E, Stürzl, M, Butter, F, Sticherling, M, Finotto, S, Kreuter, A, Kaplan, M, Jüngel, A, Gay, S, Nutt, SL, Boykin, DW, Poon, GMK, Distler, O, Schett, G, Distler, JHW & Ramming, A 2019, 'PU.1 controls fibroblast polarization and tissue fibrosis', Nature, vol. 566, no. 7744, pp. 344-349. https://doi.org/10.1038/s41586-019-0896-x
Wohlfahrt T, Rauber S, Uebe S, Luber M, Soare A, Ekici A et al. PU.1 controls fibroblast polarization and tissue fibrosis. Nature. 2019 Feb 21;566(7744):344-349. https://doi.org/10.1038/s41586-019-0896-x
Wohlfahrt, Thomas ; Rauber, Simon ; Uebe, Steffen ; Luber, Markus ; Soare, Alina ; Ekici, Arif ; Weber, Stefanie ; Matei, Alexandru Emil ; Chen, Chih Wei ; Maier, Christiane ; Karouzakis, Emmanuel ; Kiener, Hans P. ; Pachera, Elena ; Dees, Clara ; Beyer, Christian ; Daniel, Christoph ; Gelse, Kolja ; Kremer, Andreas E. ; Naschberger, Elisabeth ; Stürzl, Michael ; Butter, Falk ; Sticherling, Michael ; Finotto, Susetta ; Kreuter, Alexander ; Kaplan, Mark ; Jüngel, Astrid ; Gay, Steffen ; Nutt, Stephen L. ; Boykin, David W. ; Poon, Gregory M.K. ; Distler, Oliver ; Schett, Georg ; Distler, Jörg H.W. ; Ramming, Andreas. / PU.1 controls fibroblast polarization and tissue fibrosis. In: Nature. 2019 ; Vol. 566, No. 7744. pp. 344-349.
@article{055be31c44d149efbdbc451b82f3d3e5,
title = "PU.1 controls fibroblast polarization and tissue fibrosis",
abstract = "Fibroblasts are polymorphic cells with pleiotropic roles in organ morphogenesis, tissue homeostasis and immune responses. In fibrotic diseases, fibroblasts synthesize abundant amounts of extracellular matrix, which induces scarring and organ failure. By contrast, a hallmark feature of fibroblasts in arthritis is degradation of the extracellular matrix because of the release of metalloproteinases and degrading enzymes, and subsequent tissue destruction. The mechanisms that drive these functionally opposing pro-fibrotic and pro-inflammatory phenotypes of fibroblasts remain unknown. Here we identify the transcription factor PU.1 as an essential regulator of the pro-fibrotic gene expression program. The interplay between transcriptional and post-transcriptional mechanisms that normally control the expression of PU.1 expression is perturbed in various fibrotic diseases, resulting in the upregulation of PU.1, induction of fibrosis-associated gene sets and a phenotypic switch in extracellular matrix-producing pro-fibrotic fibroblasts. By contrast, pharmacological and genetic inactivation of PU.1 disrupts the fibrotic network and enables reprogramming of fibrotic fibroblasts into resting fibroblasts, leading to regression of fibrosis in several organs.",
author = "Thomas Wohlfahrt and Simon Rauber and Steffen Uebe and Markus Luber and Alina Soare and Arif Ekici and Stefanie Weber and Matei, {Alexandru Emil} and Chen, {Chih Wei} and Christiane Maier and Emmanuel Karouzakis and Kiener, {Hans P.} and Elena Pachera and Clara Dees and Christian Beyer and Christoph Daniel and Kolja Gelse and Kremer, {Andreas E.} and Elisabeth Naschberger and Michael St{\"u}rzl and Falk Butter and Michael Sticherling and Susetta Finotto and Alexander Kreuter and Mark Kaplan and Astrid J{\"u}ngel and Steffen Gay and Nutt, {Stephen L.} and Boykin, {David W.} and Poon, {Gregory M.K.} and Oliver Distler and Georg Schett and Distler, {J{\"o}rg H.W.} and Andreas Ramming",
year = "2019",
month = "2",
day = "21",
doi = "10.1038/s41586-019-0896-x",
language = "English (US)",
volume = "566",
pages = "344--349",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "7744",

}

TY - JOUR

T1 - PU.1 controls fibroblast polarization and tissue fibrosis

AU - Wohlfahrt, Thomas

AU - Rauber, Simon

AU - Uebe, Steffen

AU - Luber, Markus

AU - Soare, Alina

AU - Ekici, Arif

AU - Weber, Stefanie

AU - Matei, Alexandru Emil

AU - Chen, Chih Wei

AU - Maier, Christiane

AU - Karouzakis, Emmanuel

AU - Kiener, Hans P.

AU - Pachera, Elena

AU - Dees, Clara

AU - Beyer, Christian

AU - Daniel, Christoph

AU - Gelse, Kolja

AU - Kremer, Andreas E.

AU - Naschberger, Elisabeth

AU - Stürzl, Michael

AU - Butter, Falk

AU - Sticherling, Michael

AU - Finotto, Susetta

AU - Kreuter, Alexander

AU - Kaplan, Mark

AU - Jüngel, Astrid

AU - Gay, Steffen

AU - Nutt, Stephen L.

AU - Boykin, David W.

AU - Poon, Gregory M.K.

AU - Distler, Oliver

AU - Schett, Georg

AU - Distler, Jörg H.W.

AU - Ramming, Andreas

PY - 2019/2/21

Y1 - 2019/2/21

N2 - Fibroblasts are polymorphic cells with pleiotropic roles in organ morphogenesis, tissue homeostasis and immune responses. In fibrotic diseases, fibroblasts synthesize abundant amounts of extracellular matrix, which induces scarring and organ failure. By contrast, a hallmark feature of fibroblasts in arthritis is degradation of the extracellular matrix because of the release of metalloproteinases and degrading enzymes, and subsequent tissue destruction. The mechanisms that drive these functionally opposing pro-fibrotic and pro-inflammatory phenotypes of fibroblasts remain unknown. Here we identify the transcription factor PU.1 as an essential regulator of the pro-fibrotic gene expression program. The interplay between transcriptional and post-transcriptional mechanisms that normally control the expression of PU.1 expression is perturbed in various fibrotic diseases, resulting in the upregulation of PU.1, induction of fibrosis-associated gene sets and a phenotypic switch in extracellular matrix-producing pro-fibrotic fibroblasts. By contrast, pharmacological and genetic inactivation of PU.1 disrupts the fibrotic network and enables reprogramming of fibrotic fibroblasts into resting fibroblasts, leading to regression of fibrosis in several organs.

AB - Fibroblasts are polymorphic cells with pleiotropic roles in organ morphogenesis, tissue homeostasis and immune responses. In fibrotic diseases, fibroblasts synthesize abundant amounts of extracellular matrix, which induces scarring and organ failure. By contrast, a hallmark feature of fibroblasts in arthritis is degradation of the extracellular matrix because of the release of metalloproteinases and degrading enzymes, and subsequent tissue destruction. The mechanisms that drive these functionally opposing pro-fibrotic and pro-inflammatory phenotypes of fibroblasts remain unknown. Here we identify the transcription factor PU.1 as an essential regulator of the pro-fibrotic gene expression program. The interplay between transcriptional and post-transcriptional mechanisms that normally control the expression of PU.1 expression is perturbed in various fibrotic diseases, resulting in the upregulation of PU.1, induction of fibrosis-associated gene sets and a phenotypic switch in extracellular matrix-producing pro-fibrotic fibroblasts. By contrast, pharmacological and genetic inactivation of PU.1 disrupts the fibrotic network and enables reprogramming of fibrotic fibroblasts into resting fibroblasts, leading to regression of fibrosis in several organs.

UR - http://www.scopus.com/inward/record.url?scp=85061807223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061807223&partnerID=8YFLogxK

U2 - 10.1038/s41586-019-0896-x

DO - 10.1038/s41586-019-0896-x

M3 - Article

C2 - 30700907

AN - SCOPUS:85061807223

VL - 566

SP - 344

EP - 349

JO - Nature

JF - Nature

SN - 0028-0836

IS - 7744

ER -